Stock Performance Spotlight: Protagonist Therapeutics Inc (PTGX) Ends the Day at 44.95, Up by 0.27

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Protagonist Therapeutics Inc’s stock clocked out at $44.95, up 0.27% from its previous closing price of $44.83. In other words, the price has increased by $0.27 from its previous closing price. On the day, 0.57 million shares were traded. PTGX stock price reached its highest trading level at $45.6 during the session, while it also had its lowest trading level at $43.8.

Ratios:

To gain a deeper understanding of PTGX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.72. For the most recent quarter (mrq), Quick Ratio is recorded 10.70 and its Current Ratio is at 10.70. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on November 05, 2024, initiated with a Outperform rating and assigned the stock a target price of $58.

On September 24, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $65.

On September 09, 2024, Truist started tracking the stock assigning a Buy rating and target price of $60.Truist initiated its Buy rating on September 09, 2024, with a $60 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 27 ’24 when MOLINA ARTURO MD sold 26,000 shares for $44.70 per share. The transaction valued at 1,162,280 led to the insider holds 46,444 shares of the business.

MOLINA ARTURO MD sold 5,529 shares of PTGX for $252,122 on Nov 26 ’24. The Chief Medical Officer now owns 46,444 shares after completing the transaction at $45.60 per share. On Nov 25 ’24, another insider, Gupta Suneel, who serves as the Chief Development Officer of the company, sold 103,437 shares for $46.04 each. As a result, the insider received 4,762,239 and left with 256,174 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTGX now has a Market Capitalization of 2678930176 and an Enterprise Value of 2221110016. As of this moment, Protagonist’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.86. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.30 while its Price-to-Book (P/B) ratio in mrq is 5.03. Its current Enterprise Value per Revenue stands at 6.86 whereas that against EBITDA is 14.801.

Stock Price History:

Over the past 52 weeks, PTGX has reached a high of $48.89, while it has fallen to a 52-week low of $16.80. The 50-Day Moving Average of the stock is -0.64%, while the 200-Day Moving Average is calculated to be 24.32%.

Shares Statistics:

It appears that PTGX traded 678.31K shares on average per day over the past three months and 1125610 shares per day over the past ten days. A total of 57.71M shares are outstanding, with a floating share count of 56.31M. Insiders hold about 5.52% of the company’s shares, while institutions hold 100.40% stake in the company. Shares short for PTGX as of 1731628800 were 3301009 with a Short Ratio of 4.87, compared to 1728950400 on 3001498. Therefore, it implies a Short% of Shares Outstanding of 3301009 and a Short% of Float of 5.609999999999999.

Most Popular